Literature DB >> 9663801

Epileptic seizures in patients with multiple sclerosis. Is the prognosis of epilepsy underestimated?

B A Engelsen1, M Grønning.   

Abstract

The exact prevalence of epileptic seizures in patients with multiple sclerosis (MS) is still a matter of some controversy. In a population-based, unselected group of 423 patients with MS we identified 17 (4.02%) with epileptic seizures. The mean age at onset of MS was 25.2 years and at onset of epilepsy 32.6 years. A prevalence of 'active epilepsy', i.e. seizures within the last 5 years, was estimated to 3.2%. The prevalence of epilepsy in our MS population is much higher than should be expected when compared to lifetime prevalence of epilepsy in corresponding age groups. The occurrence of convulsive status epilepticus is also higher than expected, and suggests a rather serious prognosis. Thus, drug treatment should be considered after the first epileptic seizure.

Entities:  

Mesh:

Year:  1997        PMID: 9663801     DOI: 10.1016/s1059-1311(97)80037-4

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  14 in total

1.  Chronic demyelination-induced seizures.

Authors:  Andrew S Lapato; Jenny I Szu; Jonathan P C Hasselmann; Anna J Khalaj; Devin K Binder; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2017-01-30       Impact factor: 3.590

Review 2.  Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.

Authors:  Brendan J Kelley; Moses Rodriguez
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

3.  Can neural network able to estimate the prognosis of epilepsy patients according to risk factors?

Authors:  Kezban Aslan; Hacer Bozdemir; Cenk Sahin; S Noyan Ogulata
Journal:  J Med Syst       Date:  2009-03-28       Impact factor: 4.460

4.  Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.

Authors:  Lisa Langenbruch; Julia Krämer; Sati Güler; Gabriel Möddel; Sophia Geßner; Nico Melzer; Christian E Elger; Heinz Wiendl; Thomas Budde; Sven G Meuth; Stjepana Kovac
Journal:  J Neurol       Date:  2019-05-08       Impact factor: 4.849

Review 5.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

6.  Extensive cortical inflammation is associated with epilepsy in multiple sclerosis.

Authors:  Massimiliano Calabrese; Nicola De Stefano; Matteo Atzori; Valentina Bernardi; Irene Mattisi; Luigi Barachino; Luciano Rinaldi; Aldo Morra; Matthew M J McAuliffe; Paola Perini; Leontino Battistin; Paolo Gallo
Journal:  J Neurol       Date:  2008-01-31       Impact factor: 4.849

Review 7.  Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Omid Mirmosayyeb; Vahid Shaygannejad; Nasim Nehzat; Aida Mohammadi; Mahsa Ghajarzadeh
Journal:  Int J Prev Med       Date:  2021-02-24

Review 8.  A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Stephen Reingold; Olaf Stuve
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 9.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

10.  Seizure in Iranian patients with multiple sclerosis.

Authors:  Mohammad Zare; Rasul Norouzi; Vahid Shayegannejad; Fereshteh Ashtari; Majid Ghasemi; Hemaseh Tavahen; Ali Masaeli
Journal:  J Res Med Sci       Date:  2013-07       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.